(Q28368312)

English

Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models (English)

0 references

main subject

Cryptosporidium parvum

1 reference

C M Theodos

1

0 references

J K Griffiths

series ordinal

2

0 references

J D'Onfro

series ordinal

3

0 references

A Fairfield

series ordinal

4

0 references

S Tzipori

series ordinal

5

0 references

language of work or name

English

0 references

publication date

August 1998

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

42

0 references

issue

8

0 references

page(s)

1959-65

0 references

cites work

In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

20 March 2017

Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

29 September 2017

In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

29 September 2017

Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

29 September 2017

Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

29 September 2017

Cryptosporidium and cryptosporidiosis in man and animals.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

29 September 2017

Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

29 September 2017

Cryptosporidiosis: laboratory investigations and chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

2 June 2018

Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

2 June 2018

In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

2 June 2018

In vitro screening of therapeutic agents against Cryptosporidium: hyperimmune cow colostrum is highly inhibitory

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

2 June 2018

Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105716

retrieved

27 November 2018

Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9687390

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.42.8.1959

0 references

PMC publication ID

105716

0 references

PubMed publication ID

9687390

0 references

(Q28368312)

Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)